科麥迪克斯公司
US ˙ NasdaqGM ˙ US21900C3088

SecurityCRMD / CorMedix Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership111,357 shares
Latest Disclosed Value $ 1,371,918
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 7.79% increase in ownership of CRMD / CorMedix Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 111,357 shares of CorMedix Inc. (US:CRMD) valued at $1,371,918 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 103,308 shares of CorMedix Inc.. This represents a change in shares of 7.79% during the quarter. The current value of the position is $930,945 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP CorMedix EC US21900C3088 111,357 8,049 7.79 1,372 115.57 0.0308
2025-05-28 2025-03-31 NP CorMedix EC US21900C3088 103,308 8,525 8.99 636 -17.08 0.0153
2025-02-25 2024-12-31 NP CorMedix EC US21900C3088 94,783 -14,346 -13.15 768 -12.94 0.0168
2024-11-26 2024-09-30 NP CorMedix EC US21900C3088 109,129 0 0.00 882 86.65 0.0167
2024-08-26 2024-06-30 NP CorMedix EC US21900C3088 109,129 9,286 9.30 473 11.58 0.0096
2024-05-28 2024-03-31 NP CorMedix EC US21900C3088 99,843 0 0.00 423 12.80 0.0088
2024-02-26 2023-12-31 NP CorMedix EC US21900C3088 99,843 11,426 12.92 375 14.68 0.0080
2023-11-28 2023-09-30 NP CorMedix EC US21900C3088 88,417 13,584 18.15 327 10.47 0.0085
2023-08-25 2023-06-30 NP CorMedix EC US21900C3088 74,833 22,736 43.64 297 3.86 0.0070
2022-05-26 2022-03-31 NP CorMedix EC US21900C3088 52,097 0 0.00 285 20.25 0.0067
2022-02-25 2021-12-31 NP CorMedix EC US21900C3088 52,097 0 0.00 237 -2.07 0.0051
2021-11-24 2021-09-30 NP CorMedix EC US21900C3088 52,097 0 0.00 242 -32.21 0.0053
2021-08-26 2021-06-30 NP CorMedix EC US21900C3088 52,097 0 0.00 357 -31.35 0.0077
2021-05-27 2021-03-31 NP CorMedix EC US21900C3088 52,097 10,809 26.18 520 69.93 0.0118
2021-02-25 2020-12-31 NP CorMedix EC US21900C3088 41,288 0 0.00 307 23.39 0.0079
2020-11-25 2020-09-30 NP CorMedix EC US21900C3088 41,288 0 0.00 249 -4.62 0.0080
2020-08-27 2020-06-30 NP CorMedix EC US21900C3088 41,288 0 0.00 260 75.68 0.0085
2020-06-01 2020-03-31 NP CorMedix EC US21900C3088 41,288 5,609 15.72 148 -42.86 0.0061
2020-02-27 2019-12-31 NP CorMedix EC 21900C308 35,679 0 0.00 260 14.10 0.0078
2019-11-27 2019-09-30 NP CorMedix EC US21900C3088 35,679 35,679 228 0.0075
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.